Clinical Trial Update: Anti-CD38 Antibody Treating Evans Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in China is evaluating an anti-CD38 antibody for Evans syndrome, with patient recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Evans Syndrome

Drugs mentioned

• Anti-CD38 antibody

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Evan Syndrome, Treatment | Phase 2 | Status: RECRUITING